LAB Stock Summary and Trading Ideas (Standard Biotools | NASDAQ:LAB)

Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. The company operates in one segment. Its technology includes: Genomics; Single-cell proteomics; Spatial proteomics. Its platforms include: Biomark X9 System, CyTOF XT system, and Hyperion XTi Imaging System. The company offers a diverse range of instrumentation, consumables, and services that generate high-quality data across early discovery, translational and clinical research. Geographically, it operates in Americas; EMEA and Asia-Pacific.

What symbol and exchange does Standard Biotools shares trade?

Standard Biotools trades on the NASDAQ stock market under the symbol LAB.

What is Standard Biotools stock price doing today?

As of April 22, 2026, LAB stock price declined to $0.94 with 2,439,458 million shares trading.

What is Standard Biotools's Beta?

LAB has a beta of 1.78, meaning it tends to be more sensitive to market movements. LAB has a correlation of 0.17 to the broad based SPY ETF.

How much is Standard Biotools worth?

LAB has a market cap of $367.53 million. This is considered a Small Cap stock.

How much money does Standard Biotools make?

Last quarter Standard Biotools reported $24 million in Revenue and $.05 earnings per share. This beat revenue expectation by $5 million and exceeded earnings estimates by $.09.

What is the highest and lowest price Standard Biotools traded in the last 3 year period?

In the last 3 years, LAB traded as high as $3.16 and as low as $.87.

What are the top ETFs holding Standard Biotools?

The top ETF exchange traded funds that LAB belongs to (by Net Assets): VTI, IWM, VXF, IBB, IWN.

Is Standard Biotools (LAB) a good investment?

LAB has underperformed the market in the last year with a price return of -20.8% while the SPY ETF gained +39.8%. LAB has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -42.5% and +1.9%, respectively, while the SPY returned +4.0% and +7.9%, respectively.

What are the support and resistance levels for Standard Biotools (LAB)?

LAB support price is $.92 and resistance is $1.00 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that LAB shares will trade within this expected range on the day.